Propanc Biopharma Requests Foreign Filing License from Spain for Methods of Treating Resistant Cancer and Fibrosis GlobeNewswire December 01, 2025 MELBOURNE, Australia, Dec. 01, 2025 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel treatments for recurrent and metastatic cancer, today announced that it has submitted a […]

iVisa emerges as a travel tech leader: Bootstrapped, borderless, and booming A conversation with iVisa co-founders David Perez and Sergio Merino on how they are changing how the world travels. GlobeNewswire December 01, 2025 Miami, Florida, Dec. 01, 2025 (GLOBE NEWSWIRE) — In the travel-tech space, growth is often noisy. But earning a spot on

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (NASDAQ: DXCM) GlobeNewswire December 01, 2025 NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Freeport-McMoran Inc. (NYSE: FCX) GlobeNewswire December 01, 2025 NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or

ConnectM Delivers on Turnaround Plan: Back to OTCQB and Aiming for National Exchange Uplisting Company moved from Expert Market to OTCQB, restored SEC reporting, continues to grow revenue and builds Keen Labs platform in fast-growing battery and energy storage markets GlobeNewswire December 01, 2025 MARLBOROUGH, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — ConnectM Technology Solutions,

(NASDAQ:CYTK),(NASDAQ:FTRE),(NYSE:IBTA),(NASDAQ:WBTN), PHILADELPHIA, Dec. 01, 2025 (GLOBE NEWSWIRE) — Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you purchased Cytokinetics, Inc. (NASDAQ: CYTK) shares prior to December

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your Behalf GlobeNewswire December 01, 2025 PHILADELPHIA, Dec. 01, 2025 (GLOBE NEWSWIRE) — Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims

If medicine is the epitome of human-centric, White Coat Web questions why practices are letting machines speak for them-and shows them why they shouldn't. White Coat Web has been providing Medical Marketing Services for small and mid-sized practices since before the pandemic. Founded with the goal of democratizing access to healthcare and helping patients find

Montway Auto Transport, one of the nation's leading third-partylogisticsbrokerages, today announced the rollout of Two-Factor Authentication (2FA) for all vehicle pickups managed through its VIP Relocation service. The new verification step ensures vehicles are handed off only to authorized recipients, aiming to strengthen consumer protection, reduce fraud, and increase confidence throughout the vehicle transport process.

News provided by World News Media World Finance proudly announces the publication of its Winter 2025-26 edition, which explores the forces reshaping global markets at a pivotal moment of technological acceleration and geopolitical uncertainty. The front cover investigates 'The Architect of Our AI Future' – a deep examination of OpenAI CEO Sam Altman's unprecedented influence